Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

NCT00143520 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Rivoglitazone
DRUG: Pioglitazone
DRUG: Placebo

Sponsor

Daiichi Sankyo